Background and Aim: Few comprehensive epidemiological studies of the prevalence of tinnitus have been undertaken, and none has been carried out in Egypt. A community-based survey was conducted in the Assiut Governorate to estimate the prevalence of tinnitus, its associations with psychiatric disorders and its effect on the quality of life. Material and Methods: The study involved 8,484 subjects, 5,783 (68.2%) from the rural community and 2,701 (31.8%) from the urban community. Patients were identified from a door-to-door survey and evaluated using a semistructured questionnaire, the Tinnitus Handicap Inventory and the Hamilton Anxiety and Depression Scales. Results: Four hundred and thirty-nine patients with tinnitus were found, giving a prevalence of 5.17 tinnitus cases/100 inhabitants. Males and females were equally affected. The highest age-specific prevalence rate was recorded among subjects above 60 years (17.66%) and was significantly higher among urban than rural inhabitants (6.3 vs. 4.6%) and among illiterate than among educated persons (10.15 vs. 3.07%). A majority of patients (53.3%) had some hearing loss; otitis media was common. Only 15.2% of cases were classified as having severe to catastrophic tinnitus. Nearly two thirds had a degree of depression. There were significant correlations between the severity of tinnitus and the degree of hearing loss, temporomandibular joint pain and the Hamilton depression score. Sleep disturbance was reported by 39.4% of subjects. Life enjoyment was severely affected in 15% of tinnitus patients. Conclusion: Tinnitus is a common problem in our locality, especially in older adults, and is associated with some modifiable risk factors.

Keywords:
Tinnitus prevalence, Depression, Hearing loss
This content is only available via PDF.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.